Medicamen Biotech Limited
MEDICAMEQ
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Jun 202644
Quarter ₹ crore YoY Jun 2024 41 +2.4% Sept 2024 43 +0.4% Dec 2024 41 -6.9% Mar 2025 26 -42.2% Jun 2025 38 -7.3% Sept 2025 42 -1.4% Dec 2025 43 +5.7% Mar 2026 55 +110.3% Jun 2026 44 +14.1% - ₹ crore
Jun 20260.86
Quarter ₹ crore Jun 2024 0.58 Sept 2024 0.29 Dec 2024 0.14 Mar 2025 5 Jun 2025 0.47 Sept 2025 0.37 Dec 2025 0.53 Mar 2026 2 Jun 2026 0.86 - ₹ crore
Jun 202645
Quarter ₹ crore Jun 2024 42 Sept 2024 43 Dec 2024 41 Mar 2025 31 Jun 2025 39 Sept 2025 43 Dec 2025 44 Mar 2026 56 Jun 2026 45 - Cost structure
- ₹ crore
Jun 20266
Quarter ₹ crore Jun 2024 5 Sept 2024 5 Dec 2024 5 Mar 2025 6 Jun 2025 5 Sept 2025 6 Dec 2025 6 Mar 2026 6 Jun 2026 6 - ₹ crore
Jun 202641
Quarter ₹ crore Jun 2024 39 Sept 2024 40 Dec 2024 38 Mar 2025 28 Jun 2025 37 Sept 2025 40 Dec 2025 41 Mar 2026 53 Jun 2026 41 - Exceptional items and tax
- ₹ crore
Jun 20263
Quarter ₹ crore Jun 2024 3 Sept 2024 3 Dec 2024 3 Mar 2025 3 Jun 2025 2 Sept 2025 3 Dec 2025 3 Mar 2026 4 Jun 2026 3 - ₹ crore
Jun 20260.73
Quarter ₹ crore Jun 2024 0.76 Sept 2024 0.99 Dec 2024 0.96 Mar 2025 0.63 Jun 2025 0.53 Sept 2025 0.56 Dec 2025 0.49 Mar 2026 0.56 Jun 2026 0.73 - Profit
- ₹ crore
Jun 20263
Quarter ₹ crore YoY Jun 2024 2 -48.9% Sept 2024 2 -24.7% Dec 2024 3 -8.8% Mar 2025 2 -22.3% Jun 2025 2 -27.5% Sept 2025 2 -2.8% Dec 2025 3 +2.8% Mar 2026 3 +23.3% Jun 2026 3 +54.4% - Per share
- ₹ per share
Jun 20261.86
Quarter ₹ per share Jun 2024 1.78 Sept 2024 0.00 Dec 2024 1.98 Mar 2025 1.90 Jun 2025 1.21 Sept 2025 1.63 Dec 2025 1.91 Mar 2026 2.19 Jun 2026 1.86
| ₹ crore | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 41 | 43 | 41 | 26 | 38 | 42 | 43 | 55 | 44 | |
| Revenue YoY | +2.4% | +0.4% | -6.9% | -42.2% | -7.3% | -1.4% | +5.7% | +110.3% | +14.1% |
| 0.58 | 0.29 | 0.14 | 5 | 0.47 | 0.37 | 0.53 | 2 | 0.86 | |
| 42 | 43 | 41 | 31 | 39 | 43 | 44 | 56 | 45 | |
| Cost structure | |||||||||
| 5 | 5 | 5 | 6 | 5 | 6 | 6 | 6 | 6 | |
| 39 | 40 | 38 | 28 | 37 | 40 | 41 | 53 | 41 | |
| Exceptional items and tax | |||||||||
| 3 | 3 | 3 | 3 | 2 | 3 | 3 | 4 | 3 | |
| 0.76 | 0.99 | 0.96 | 0.63 | 0.53 | 0.56 | 0.49 | 0.56 | 0.73 | |
| Profit | |||||||||
| 2 | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | |
| Net profit YoY | -48.9% | -24.7% | -8.8% | -22.3% | -27.5% | -2.8% | +2.8% | +23.3% | +54.4% |
| Per share | |||||||||
| 1.78 | 0.00 | 1.98 | 1.90 | 1.21 | 1.63 | 1.91 | 2.19 | 1.86 | |
Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.